This activity has expired. Credit is no longer available.
This activity is supported by independent educational grants from AstraZeneca and Bristol-Myers Squibb.

Non-Small Cell Lung Cancer

Whitney Lewis, PharmD, BCOP
The University of Texas MD Anderson Cancer Center

The role of immunotherapy in non–small cell lung cancer has been rapidly expanding as results from several clinical trials have come out in recent years. Takeaways from these studies and a differential diagnosis of a case study patient with anemia and nephritis demonstrate key points advanced practitioners should be aware of when managing this patient population.


Download Slides

These activities, certified for CME/CE/CPE credit, are jointly provided by

Annenberg Logo Harborside Press Logo

in collaboration with

Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.